C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2006
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	CN1863889A Fluorescent compound
11/15/2006	CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006	CN1863777A Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
11/15/2006	CN1863772A Process for preparing an azabicyclo[3.1.0] hexane compound
11/15/2006	CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes
11/15/2006	CN1863752A Copper catalyzed arylation
11/15/2006	CN1863528A Indoles and azaindoles as antiviral agents
11/15/2006	CN1863527A 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
11/15/2006	CN1862871A Electrolytic solution and battery
11/14/2006	US7135598 N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof
11/14/2006	US7135577 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom
11/14/2006	US7135576 Process for preparing glycidylphthalimide
11/14/2006	US7135495 Indole derivatives
11/14/2006	US7135494 Antitumoral carbazoles
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	CA2156432C New derivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learning
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/09/2006	WO2006119104A2 Process for preparing isatins with control of side-product formation
11/09/2006	WO2006118955A2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/09/2006	WO2006117754A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
11/09/2006	WO2006117669A1 Amide resorcinol compounds
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	WO2006116953A1 A method for the preparation of tegaserod and slected salts thereof
11/09/2006	WO2006116872A1 Methods for hormone profiling
11/09/2006	WO2006028963A3 Substituted heterocyclic compounds and uses thereof
11/09/2006	WO2005112639A3 Treatment or prevention of respiratory viral infections with immunomodulator compounds
11/09/2006	US20060252942 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one
11/09/2006	US20060252938 Process for the separation of palladium catalyst from crude reaction mixtures of aryl acetic acids obtained by carbonylation
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252813 Apparatus for curing a composite laminate
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006	US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
11/09/2006	US20060252104 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
11/09/2006	US20060251925 Aromatic amine derivative and organic electroluminescence device using the same
11/09/2006	CA2605985A1 Amide resorcinol compounds
11/09/2006	CA2603818A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/09/2006	CA2599411A1 Enzyme inhibitors
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1719760A2 Fluvastatin sodium crystal form LXXXVII, processes for preparing it, compositions containing it and methods of using it
11/08/2006	EP1719759A2 Fluvastatin sodium crystal form LXXIII, processes for preparing it, compositions containing it and methods of using it
11/08/2006	EP1719758A1 Process for producing monatin
11/08/2006	EP1718639A2 Caspase inhibitors and uses thereof
11/08/2006	EP1718621A2 Nitroxyl progenitor compounds and methods of use
11/08/2006	EP1718612A1 Novel benzofurans and indols
11/08/2006	EP1718611A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
11/08/2006	EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1860364A Fluorescently tagged ligands
11/08/2006	CN1860112A 3-amino chroman and 2-amino tetralin derivatives
11/08/2006	CN1283682C Indole resins, epoxy resins, and resin compositions containing the same
11/08/2006	CN1283643C Preparation of S-tricyctic lactone
11/08/2006	CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006	CN1283637C Substd. N-Benzyl-indol-3-yl glyoxylic acid derivs. having anti-tumoral effect
11/07/2006	US7132550 Process for the preparation of cyanine dyes with polysulfonate anions
11/07/2006	US7132549 Process
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132455 Phthalamide derivatives
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132209 Organophotoreceptor with charge transport material having three arylamino groups
11/07/2006	CA2260943C Formulation of 5-ht agonists
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/02/2006	WO2006115115A1 Combined pharmaceutical preparation for treatment of type 2 diabetes
11/02/2006	WO2006114402A1 Substituted octahydroisoindoles as antagonists of melanin concentrating hormone receptor 1 (mch1r)
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006061392A3 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
11/02/2006	WO2005117872A3 Dual acting snri-nmda antagonists for the treatment of genitourinary disorders
11/02/2006	WO2005028624A3 Molecular scaffolds for kinase ligand development
11/02/2006	US20060247442 Process for preparing isatins with control of side-product formation
11/02/2006	US20060247441 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/02/2006	US20060247298 {[((1E)-{4-[3-(4-tert-butylphenoxy)prop-1-ynyl]phenyl}methylidene)amino]oxy}acetic acid; plasminogen activator inhibitor, anticoagulant; venous, arterial, cerebral, and deep vein thrombosis, atrial fibrillation, pulmonary fibrosis, myocardial ischemia, atherosclerotic plaque formation
11/02/2006	US20060247297 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
11/02/2006	US20060247296 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
11/02/2006	US20060247225 e.g. (1 alpha ,5 alpha ,6 alpha )-N-[3-(4-methyl-3-pentenyl)-3-azabicyclo[3.1.0]hex-6-yl]-2-hydroxy-2-cyclopentyl-2-(4-methoxy)phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
11/02/2006	US20060246377 Suitable as photolatent acids in ArF resist technology; thermally stable, even at high bake temperatures during processing and provide high photospeed; surface coatings, printing inks, printing plates, dental formulations, colour filters, resists, or image-recording materials, photoresist
11/02/2006	US20060246023 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/02/2006	EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716100A2 Therapeutic amide derivatives
11/02/2006	EP1716087A1 Process for c-c coupling between electrophilic substrates and pi-nucleophiles in neutral to basic acqueous or alcoholic solvents without the use of a lewis or proteic acid.
11/02/2006	EP1715921A2 Tetrahydroindolone derivatives for treatment of neurological conditions
11/02/2006	EP1585744B1 Process for making ondansetron and intermediates thereof
11/02/2006	EP1556037B1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity
11/02/2006	EP1432428B1 Agent for colouring fibres containing keratin
11/02/2006	EP1419126B1 Fluorous nucleophilic substitution of alcohols and reagents for use therein
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1349535B1 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	CA2605302A1 Combined pharmaceutical preparation for treatment of type 2 diabetes
11/02/2006	CA2604531A1 Vla-4 antagonists
11/01/2006	CN1856313A Therapeutic compounds

1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 458